PagrindinisSHPMY • OTCMKTS
add
Shanghai Pharmaceuticals Holdings ADR
Ankstesnė uždarymo kaina
7,92 $
Metų intervalas
6,46 $ - 10,47 $
Bendroji vertė rinkoje
67,62 mlrd. HKD
Vidutinė prekybos apimtis
1,41 tūkst.
Rinkos naujienos
Finansiniai rodikliai
Pajamų ataskaita
Pajamos
Grynosios pajamos
| (CNY) | 2024-03info | Metinis pokytis |
|---|---|---|
Pajamos | 70,15 mlrd. | 5,93 % |
Veiklos sąnaudos | 5,65 mlrd. | −4,06 % |
Grynosios pajamos | 1,54 mlrd. | 1,62 % |
Grynojo pelno marža | 2,20 | −3,93 % |
Pelnas tenkantis vienai akcijai | — | — |
EBITDA | 2,71 mlrd. | −13,23 % |
Taikomas mokesčio tarifas | 22,80 % | — |
Balansas
Visas turtas
Visi įsipareigojimai
| (CNY) | 2024-03info | Metinis pokytis |
|---|---|---|
Lėšos, trump. investicijos | 37,18 mlrd. | −2,45 % |
Visas turtas | 217,42 mlrd. | 5,52 % |
Visi įsipareigojimai | 135,33 mlrd. | 7,27 % |
Visos paprastosios akcijos | 82,09 mlrd. | — |
Išleistos akcijos | 3,70 mlrd. | — |
Kaina / apskaitinė vertė | 0,42 | — |
Turto grąža | 2,77 % | — |
Kapitalo grąža | 4,41 % | — |
Pinigų srautas
Grynasis pokytis (grynaisiais pinigais)
| (CNY) | 2024-03info | Metinis pokytis |
|---|---|---|
Grynosios pajamos | 1,54 mlrd. | 1,62 % |
Pinigai iš operacijų | −5,47 mlrd. | −108,65 % |
Pinigai iš investicijų | 1,84 mlrd. | 187,44 % |
Pinigai iš finansavimo | 3,25 mlrd. | −24,64 % |
Grynasis pokytis (grynaisiais pinigais) | −373,88 mln. | 12,88 % |
Laisvas pinigų srautas | −7,83 mlrd. | −33,74 % |
Apie
Shanghai Pharmaceuticals is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Įkurta
1994-01-18
Svetainė
Darbuotojų skaičius
48 164
